SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-10-018513
Filing Date
2010-04-05
Accepted
2010-04-05 16:33:36
Documents
1
Period of Report
2010-03-17

Document Format Files

Seq Description Document Type Size
1 v180065_ex.html 4/A  
1 v180065_ex.xml 4/A 4344
  Complete submission text file 0001144204-10-018513.txt   6141
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 4300 44TH ST SE GRAND RAPIDS MI 49512
Business Address
CHOWNING MARY E (Reporting) CIK: 0001257133 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-32715 | Film No.: 10731468